Top compounds associated with response to OR5T2


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.07 0.02
mRNA AICAR GDSC1000 pan-cancer AAC 0.075 0.02
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.073 0.02
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.063 0.03
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.067 0.03
mRNA GDC-0941 gCSI pan-cancer AAC 0.13 0.03
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.07 0.04
mRNA tivozanib GDSC1000 pan-cancer AAC 0.071 0.04
mRNA masitinib GDSC1000 pan-cancer AAC 0.066 0.04
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.064 0.04
Download CSV